INTRODUCTION: Sero-epidemiological studies of herpes simplex virus (HSV) type 2 infection in Africa remain difficult to interpret as a result of the high rate of false-positive results observed when using the new recombinant gG2 HSV-2 ELISA tests. The performance of two widely used gG2 ELISA was compared to derive an appropriate testing algorithm for use in South Africa. METHODS: Sera from 210 women attending family planning clinics in Johannesburg were tested using HerpeSelect and Kalon HSV-2 gG2 assays. Sera from 20 discordant pairs, 44 concordant positive and 33 concordant negative samples were further tested by HSV Western blot. The sensitivity and specificity of each test and of combination algorithms compared with Western blot were calculated. RESULTS: HerpeSelect had a sensitivity of 98% (95% CI 95 to 100) and specificity of 61% (95% CI 48 to 74). Kalon was less sensitive (89%, 95% CI 83 to 94) but more specific (85%, 95% CI 61 to 100). Seroprevalence may have been overestimated by as much as 14% by HerpeSelect. Specificity was improved by raising the cut-off index for the determination of a positive result for HerpeSelect (to >or=3.5), but not for Kalon. HIV-1 infection reduced the specificity of HerpeSelect to 30%. Improved sensitivity and specificity were obtained by a two-test algorithm using HerpeSelect (>or=3.5) as the first test and Kalon to resolve equivocal results (sensitivity 92%, 95% CI 82 to 98; specificity 91%, 95% CI 79 to 98). CONCLUSION: Newer HSV-2 serological tests have low specificity in this South African population with a high HIV-1 prevalence. Two-step testing strategies could provide rational testing alternatives to Western blot.
INTRODUCTION: Sero-epidemiological studies of herpes simplex virus (HSV) type 2 infection in Africa remain difficult to interpret as a result of the high rate of false-positive results observed when using the new recombinant gG2 HSV-2 ELISA tests. The performance of two widely used gG2 ELISA was compared to derive an appropriate testing algorithm for use in South Africa. METHODS: Sera from 210 women attending family planning clinics in Johannesburg were tested using HerpeSelect and Kalon HSV-2 gG2 assays. Sera from 20 discordant pairs, 44 concordant positive and 33 concordant negative samples were further tested by HSV Western blot. The sensitivity and specificity of each test and of combination algorithms compared with Western blot were calculated. RESULTS: HerpeSelect had a sensitivity of 98% (95% CI 95 to 100) and specificity of 61% (95% CI 48 to 74). Kalon was less sensitive (89%, 95% CI 83 to 94) but more specific (85%, 95% CI 61 to 100). Seroprevalence may have been overestimated by as much as 14% by HerpeSelect. Specificity was improved by raising the cut-off index for the determination of a positive result for HerpeSelect (to >or=3.5), but not for Kalon. HIV-1 infection reduced the specificity of HerpeSelect to 30%. Improved sensitivity and specificity were obtained by a two-test algorithm using HerpeSelect (>or=3.5) as the first test and Kalon to resolve equivocal results (sensitivity 92%, 95% CI 82 to 98; specificity 91%, 95% CI 79 to 98). CONCLUSION: Newer HSV-2 serological tests have low specificity in this South African population with a high HIV-1 prevalence. Two-step testing strategies could provide rational testing alternatives to Western blot.
Authors: C Y Chen; R C Ballard; C M Beck-Sague; Y Dangor; F Radebe; S Schmid; J B Weiss; V Tshabalala; G Fehler; Y Htun; S A Morse Journal: Sex Transm Dis Date: 2000-01 Impact factor: 2.830
Authors: B Auvert; R Ballard; C Campbell; M Caraël; M Carton; G Fehler; E Gouws; C MacPhail; D Taljaard; J Van Dam; B Williams Journal: AIDS Date: 2001-05-04 Impact factor: 4.177
Authors: J S Smith; R C Bailey; D J Westreich; I Maclean; K Agot; J O Ndinya-Achola; W Hogrefe; R A Morrow; S Moses Journal: Sex Transm Infect Date: 2008-10-27 Impact factor: 3.519
Authors: Oliver Laeyendecker; Charla Henson; Ronald H Gray; Ruby H-N Nguyen; Bobbi Jo Horne; Maria J Wawer; David Serwadda; Noah Kiwanuka; Rhoda Ashley Morrow; Wayne Hogrefe; Thomas C Quinn Journal: J Clin Microbiol Date: 2004-04 Impact factor: 5.948
Authors: Edith Nakku-Joloba; Fred Kambugu; Julius Wasubire; Joshua Kimeze; Robert Salata; Jeffrey M Albert; Alfred Rimm; Christopher Whalen Journal: Afr Health Sci Date: 2014-12 Impact factor: 0.927
Authors: Musa Otieno Ng'ayo; David Friedrich; King K Holmes; Elizabeth Bukusi; Rhoda Ashley Morrow Journal: J Virol Methods Date: 2009-10-23 Impact factor: 2.014
Authors: Molly Rosenberg; Audrey Pettifor; Sheri A Lippman; Harsha Thirumurthy; Michael Emch; William C Miller; Amanda Selin; Francesc Xavier Gómez-Olivé; James P Hughes; Oliver Laeyendecker; Stephen Tollman; Kathleen Kahn Journal: Sex Transm Dis Date: 2015-05 Impact factor: 2.830
Authors: Marie C D Stoner; Nadia Nguyen; Kelly Kilburn; F Xavier Gómez-Olivé; Jessie K Edwards; Amanda Selin; James P Hughes; Yaw Agyei; Catherine Macphail; Kathleen Kahn; Audrey Pettifor Journal: AIDS Date: 2019-01-27 Impact factor: 4.177
Authors: Salim S Abdool Karim; Quarraisha Abdool Karim; Ayesha B M Kharsany; Cheryl Baxter; Anneke C Grobler; Lise Werner; Angela Kashuba; Leila E Mansoor; Natasha Samsunder; Adrian Mindel; Tanuja N Gengiah Journal: N Engl J Med Date: 2015-08-06 Impact factor: 91.245
Authors: Jessica Vig; Kim S Miller; Catherine Chirwa-Motswere; Kate Winskell; Elizabeth Stallcup Journal: Afr J AIDS Res Date: 2016 Impact factor: 1.300
Authors: Payal Chakraborty; Alison H Norris; Sarah Huber-Krum; Sarah Garver; Robert B Hood; Venson Banda; Allahna Esber; Carr Reese Patricia; Robert Krysiak; Abigail Norris Turner Journal: Sex Transm Dis Date: 2020-03 Impact factor: 3.868